arrow
D

Daniel Bergemalm

orebro university
H指数:24
被引数:2,265

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Building a Robust Investigator-Initiated Platform: The I-CARE Experience

构建一个稳健的 investigator-initiated 平台:I-CARE 经验

2026-02-150
OAAI
NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD

NORDTREAT:一项随机、多中心、生物标志物策略设计、开放标签、对照试验,比较顶线治疗与临床管理在 newly diagnosed IBD 中的效果

2026-01-010
PRE
A proximity extension assay-based serum assay enabling absolute quantification of prognostic proteins in inflammatory bowel disease: Development and Analytical Validation

基于邻近延伸分析的血清检测方法可实现炎症性肠病中预后蛋白的绝对定量:开发与分析验证

2026-01-010
PRE
Non-targeted lipidomic profiling reveals distinct molecular signatures in inflammatory bowel disease: Discovery and validation in two inception cohorts

非靶向脂质组学分析揭示炎症性肠病的特异分子特征:两项起始队列的研究发现与验证

2026-01-010
PRE
A protein signature for prediction of disease course in newly diagnosed Ulcerative Colitis

新诊断溃疡性结肠炎疾病进程预测的蛋白质标志物

2026-01-010
PRE
Preclinical Anti-Integrin αvβ6 Autoantibodies in Ulcerative Colitis: Validation of Predictive Performance, Early Life Emergence and Environmental Modifiers across Multiple Population-Based Cohorts

溃疡性结肠炎中抗整合素αvβ6自身抗体的临床前研究:预测性能验证、早期生命出现及在多个基于人群队列中的环境修饰因素

2026-01-010
PRE
The exposome metabolome in paediatric inflammatory bowel disease: A cross-sectional study in a population-based Norwegian cohort

环境暴露组与代谢组在儿科炎症性肠病中的关系:一项基于挪威人群队列的横断面研究

2026-01-010
PRE
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis

托法替布与乌帕替尼治疗急性重度溃疡性结肠炎的疗效比较

2025-07-260
OAAI
Healthcare resource utilization and production loss in vedolizumab-treated inflammatory bowel disease patients: results from the Swedish prospective multicentre SVEAH study

vedolizumab治疗的炎症性肠病患者医疗资源利用和生产损失:来自瑞典前瞻性多中心SVEAH研究的结果

2025-07-170
OA
Reply

回复

2025-06-230
PRE
Anti-integrin αvβ6 IgG antibody as a diagnostic and prognostic marker in ulcerative colitis: A cross-sectional and longitudinal study defining a specific disease phenotype

抗整合素αvβ6 IgG抗体作为溃疡性结肠炎的诊断和预后标志物:一项定义特定疾病表型的横断面和纵向研究

2025-04-190
PRE
Trans-continental analysis of determinants of response to COVID-19 vaccination in 2268 patients with Inflammatory Bowel Disease
2025-01-220
PRE